Abstract
The ongoing surge in the elderly population, with associated financial, social and emotional costs, has increased the urgency to find treatment for diseases that afflict this segment of the population. Of major concern is the devastating condition of Alzheimer’s Disease (AD), which will affect nearly half of the population over 85 years old (Evans et al., 1989), and accounts for a tremendous proportion of caretaking and nursing home costs. The affective aspects of AD, involving loss of mental capacity with the fear and stress it engenders in victims and their families, adds an intense emotional component to the need to understand and treat this disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andrisani, O. M. and Dixon, J. E., 1990, Somatostatin gene regulation, Annu. Rev. Phvsiol., 52: 793.
Araujo, D. M., Lapchak, P. A., Collier, B., and Quirion, R., 1990, Evidence that somatostatin enhances endogenous acetylcholine release in the rat hippocampus, J. Neurochem., 55: 1546.
Arendash, G. W., Millard, W. J., Dunn, A. J. and Meyer, E. M., 1987, Long-term neuropathological and neurochemical effects of nucleus basalis lesions in the rat, Science. 238: 952.
Barnes, C. A., Mizumori, S. J. Y., Lovinger, D. M., Sheu, F.-S., Murakami, K., Chan, S. Y., Linden, D. J., Nelson, R. B. and Routtenberg, A., 1988, Selective decline in protein Fl phosphorylation in hippocampus of senescent rats, Neurobiol. Aging. 9: 393.
Beal, M. F., Mazurek, M. F., Tran, V. T., Chattha, G., Bird, E. D. and Martin, J. B., 1985, Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer’s Disease, Science, 229: 289.
Beal, M. F., Uhl, G., Mazurek, M. F., Kowall, N., and Martin, J. B., 1986, Somatostatin:Alterations in the central nervous system in neurological disease, in:“Neuropeptides in Neurologic and Psychiatric Disease”, J. B. Martin and Jack D. Barchas, eds., Raven Press, New York, NY.
Bonner, T. I., 1989, The molecular basis of muscarinic receptor diversity, TINS. 12: 148.
Brown, D. A. and Adams, P. R., 1980, Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone, Nature. 283: 673.
Chneiweiss, H., Bertrand, P. Epelbaum, J., Kordon, C., Glowinski, J., Premont, J., Enjalbert, A., 1987, Somatostatin receptors on cortical neurones and adenohypophysis:comparison between specific binding and adenylate cyclase inhibition, Eur. J. Pharm., 138: 249.
Clark, A. W., Tran, P., Aubin, S. and Zwiers, H., 1988, Altered distribution of immunoreactivity for the growth-associated protein B-50 in neuritic plaques of Alzheimer’s Disease, Neurosci. Res. Comm., 2: 53.
Cohn, M. C, and Cohn, M., 1975, “Barrel rotation” induced by somatostatin in the nonlesioned rat, Brain Res., 96:138.
Coyle, J. T., Price, D. L. and DeLong, M. R., 1983, Alzheimer’s Disease:A disorder of cortical cholinergic innervation, Science, 219: 1184.
Crews, F. T., Meyer, E. M., Gonzales, R. A., Theiss, C., Otero, D. H., Larsen, K., Raulli, R. and Calderini, G., 1986, Presynaptic and postsynaptic approaches to enhancing central cholinergic transmission, in:“Treatment Development Strategies for Alzheimer’s Disease”, T. Crook, R. Bartus, S. Ferris, and S. Gershan, eds., Mark Powley Assoc., Inc., Madison, CT.
Davies, P., Katzman, R. and Terry, R. D., 1980, Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer Disease and Alzheimer senile dementia, Nature. 288: 279.
Delfs, J. R., 1985, Somatostatin and Alzheimer’s Disease:Possible pathophysiological associations, in:“Senile Dementia of the Alzheimer Type”, Alan R. Liss, Inc., New York, NY.
Delfs, J. R., Zhu, C. H. and Dichter, M. A., 1984, Coexistence of acetylcholinesterase and somatostatin-immunoreactivity in neurons cultured from rat cerebrum, Science, 223: 61.
Dokas, L. A., and Ting, S. M., 1990, A comparison of the regulatory properties of striatal and cortical forms of adenylate cyclase, Soc. Neurosci. Abstr., 16, #538. 7.
Dokas, L. A., Zwiers, H., Coy, D. H. and Gispen, W. H., 1983, Somatostatin and analogs inhibit endogenous synaptic plasma membrane protein phosphorylation in vitro, Eur. J. Pharm., 88: 185.
Dutar, P. and Nicoll, R., 1988, Classification of muscarinic responses in hippocampus in terms of receptor subtypes and second messenger systems:electrophysiological studies in vitro, J. Neurosci., 8: 4214.
Eva, C. and Costa, E., 1987, In rat hippocampus, somatostatin 14 and muscarinic receptor ligands modulate an adenylate cyclase belonging to a common domain of the receptor, J. Pharm. Exp. Ther., 242: 888.
Evans, D. A., Funkenstein, H., Albert, M. S., Scherr, P. A., Cook, N. R, Chown, M. J., Hebert, L. E., Hennekens, C. H. and Taylor, J. O., 1989, Prevalence of Alzheimer’s disease in a community population of older persons, JAMA, 262: 2551.
Gonzales, R. A. and Crews, F. T., 1985, Guanine nucleotides stimulate production of inositol trisphosphate in rat cortical membranes, Biochem. J., 232: 799.
Gonzalez, G. A. and Montimny, M. R., 1989, Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133, Cell, 59: 675.
Greenberg, M. E., Ziff, E. B. and Greene, L. A., 1986, Stimulation of neuronal acetylcholine receptors induces rapid gene transcription, Science. 234: 80.
Haga, K. and Haga, T., 1989, Agonist-dependent phosphorylation of cerebral and atrial muscarinic receptors:blockade of the phosphorylation by GTP-binding regulatory proteins and its reversal by guanine nucleotides, Biomedical Research. 10: 293.
Haga, K., Haga, T. and Ichiyama, A., 1990, Phosphorylation by protein kinase C of the muscarinic acetylcholine receptor, J. Neurochem., 54: 1639.
Hortnagl, H., Sperk, G., Sobal, G. and Maas, D., 1990, Cholinergic deficit induced by ethylcholine aziridinium (AF64A) transiently affects somatostatin and neuropeptide Y levels in rat brain, J. Neurochem., 54: 1608.
Katada, T., Gilman, A. G., Watanabe, Y., Bauer, S. and Jakobs, K. H., 1985, Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase. Eur. J. Biochem., 151: 431.
Katzman, R. and Saitoh, T., 1991, Advances in Alzheimer’s Disease, FASEB. 5: 278.
Mancillas, J. R., Siggins, G. R. and Bloom, F. E., 1986, Somatostatin selectively enhances acetylcholine-induced excitations in rat hippocampus and cortex, Proc. Natl. Acad. Sci. USA. 83: 7518.
Moore, S. D., Madamba, S. G., Joels, M. and Siggins, G. R., 1988, Somatostatin augments the M-current in hippocampal neurons, Science. 239: 278.
Morrison, J. H., Rogers, J., Sherr, S., Benoit, R. and Bloom, F. E., 1985, Somatostatin immunoreactivity in neuritic plaques of Alzheimer’s patients, Nature. 314: 90.
Neve, R. L., Finch, E. A., Bird, E. D. and Benowitz, L. L, 1988, Growth-associated protein GAP-43 is expressed selectively in associative regions of the adult human brain, Proc. Natl. Acad. Sci. USA. 85: 3638.
Sheng, M. and Greenberg, M. E., 1990, The regulation and function of c-fos and other immediate early genes in the nervous system, Neuron. 4: 477.
Trejo, J. and Brown, J. H., 1991, c-fos and c-jun are induced by muscarinic receptor activation of protein kinase C but are differentially regulated by intracellular calcium, J., Biol. Chem., 266: 7876.
Van Dongen, C. J., Zwiers, H., De Graan, P. N. E. and Gispen, W. H., 1985, Modulation of the activity of purified phosphatidylinositol 4-phosphate kinase by phosphorylated and dephosphorylated B-50 protein, Biochem. Biophys. Res. Comm., 128: 1219.
Van Hooff, C. O. M., De Graan, P. N. E., Oestreicher, A. B. and Gispen, W. H., 1989, Muscarinic receptor activation stimulates B-50/GAP-43 phosphorylation in isolated nerve growth cones, J. Neurosci., 9: 3753.
Watson, T. W. J. and Pittman, Q. J., 1988, Pharmacological evidence that somatostatin activates the m-current in hippocampal pyramidal neurons, Neurosci. Lett., 91: 172.
Wirak, D. O., Bayney, R., Ramabhadran, T. V., Fracasso, R. P., Hart, J. T., Hauer, P. E. Hsiau, P., Pekar, S. K., Scangos, G. A., Trapp, B. D. and Unterbeck, A. J., 1991, Deposits of amyloid ß protein in the central nervous system of transgenic mice, Science. 253: 323.
Yamano M. and Luiten, P. G. M., 1989, Direct synaptic contacts of medial septal efferents with somatostatin immunoreactive neurons in the rat hippocampus, Brain Res. Bull., 22: 993.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Shaffer, L.M., Ting, Sm., Dokas, L.A. (1992). Acetylcholine-Somatostatin Interactions: Potential Implications for the Treatment of Alzheimer’s Disease. In: Meyer, E.M., Simpkins, J.W., Yamamoto, J., Crews, F.T. (eds) Treatment of Dementias. Advances in Behavioral Biology, vol 40. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3432-7_7
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3432-7_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6518-1
Online ISBN: 978-1-4615-3432-7
eBook Packages: Springer Book Archive